While in some triple-negative breast cancer cell lines DLC1 was robustly expressed most cell lines of the luminal A/B, HER2+ , and also TNA and TNB subtype showed low or barely detectable DLC1 protein expression. Here, ERBB2 is linked to triple-negative breast carcinoma.